Adiponectin in mice with altered GH action: Links to insulin sensitivity and longevity

Journal of Endocrinology

Volumn 216, Issue 3, 2013, Pages 363-374

  Lubbers, Ellen R ^a   List, Edward O ^a   Jara, Adam ^a,b   Sackman Sala, Lucila ^a   Cordoba Chacon, Jose ^c   Gahete, Manuel D ^c   Kineman, Rhonda D ^c   Boparai, Ravneet ^d   Bartke, Andrzej ^d   Kopchick, John J ^a,b   Berryman, Darlene E ^a,b  

^a OHIO UNIVERSITY   (United States)

^b OHIO UNIVERSITY   (United States)

^c JESSE BROWN VA MEDICAL CENTER   (United States)

^d SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adiponectin; Growth hormone; Growth hormone antagonist; Growth hormone deficiency; Growth hormone receptor; High molecular weight adiponectin

Indexed keywords

ADIPONECTIN; GROWTH HORMONE; INSULIN; LEPTIN; MESSENGER RNA; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FAT MASS; HORMONE ACTION; INGUINAL REGION; INSULIN SENSITIVITY; LONGEVITY; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; SIGNAL TRANSDUCTION;

ADIPONECTIN; ANIMALS; BLOOD GLUCOSE; BODY COMPOSITION; GROWTH HORMONE; INSULIN; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; LEPTIN; LONGEVITY; MICE; MICE, TRANSGENIC; RECEPTORS, SOMATOTROPIN;

EID: 84875067801     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-12-0505     Document Type: Article

References (61)

1. Alderman JM, Flurkey K, Brooks NL, Naik SB, Gutierrez JM, Srinivas U, Ziara KB, Jing L, Boysen G, Bronson R et al. 2009 Neuroendocrine inhibition of glucose production and resistance to cancer in dwarf mice. Experimental Gerontology 44 26-33. (doi:10.1016/j.exger.2008. 05.014)
2. Arai Y, Nakazawa S, Kojima T, Takayama M, Ebihara Y, Shimizu K-i, Yamamura K, Homma S, Osono Y, Gondo Y et al. 2006 High adiponectin concentration and its role for longevity in female centenarians. Geriatrics & Gerontology International 6 32-39. (doi:10.1111/j.1447-0594.2006.00304.x)
3. Arai Y, Takayama M, Abe Y & Hirose N, 2011 Adipokines and aging. Journal of Atherosclerosis and Thrombosis 18 545-550. (doi:10.5551/ jat.7039)
4. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K et al. 1999 Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochemical and Biophysical Research Communications 257 79-83. (doi:10.1006/bbrc. 1999.0255)
5. Arumugam R, Fleenor D & Freemark M, 2007 Effects of lactogen resistance and GH deficiency on mouse metabolism: pancreatic hormones,adipocytokines, and expression of adiponectin and insulin receptors. Endocrine 32 182-191. (doi:10.1007/s12020-007-9017-y)
6. Atzmon G, Pollin TI, Crandall J, Tanner K, Schechter CB, Scherer PE, Rincon M, Siegel G, Katz M, Lipton RB et al. 2008 Adiponectin levels and genotype: a potential regulator of life span in humans. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 63 447-453. (doi:10.1093/gerona/63.5.447)
7. Bartke A, 2003 Can growth hormone (GH) accelerate aging Evidence from GH-transgenic mice Neuroendocrinology 78 210-216. (doi:10.1159/ 000073704)
8. Berg AH, Combs TP, Du X, Brownlee M & Scherer PE, 2001 The adipocytesecreted protein Acrp30 enhances hepatic insulin action. Nature Medicine 7 947-953. (doi:10.1038/90992)
9. Berryman DE, List EO, Coschigano KT, Behar K, Kim JK & Kopchick JJ, 2004 Comparing adiposity profiles in three mouse models with altered GH signaling. Growth Hormone & IGF Research 14 309-318. (doi:10.1016/j. ghir.2004.02.005)
10. Berryman DE, List EO, Palmer AJ, Chung MY, Wright-Piekarski J, Lubbers E, O'Connor P, Okada S & Kopchick JJ, 2010 Two-year body composition analyses of long-lived GHR null mice. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 65 31-40. (doi:10.1093/gerona/ glp175)
11. Berryman DE, List EO, Sackmann-Sala L, Lubbers E, Munn R & Kopchick JJ, 2011 Growth hormone and adipose tissue: beyond the adipocyte. Growth Hormone & IGF Research 21 113-123. (doi:10.1016/j.ghir.2011. 03.002)
12. Bik W, Baranowska-Bik A, Wolinska-Witort E, Martynska L, Chmielowska M, Szybinska A, Broczek K & Baranowska B, 2006 The relationship between adiponectin levels and metabolic status in centenarian, early elderly, young and obese women. Neuro Endocrinology Letters 27 493-500.
13. Chen WY, White ME, Wagner TE & Kopchick JJ, 1991 Functional antagonism between endogenous mouse growth hormone (GH) and a GH analog results in dwarf transgenic mice. Endocrinology 129 1402- 1408. (doi:10.1210/endo-129-3-1402)
14. Combs TP, BergAH, RajalaMW, Klebanov S, Iyengar P, Jimenez-Chillaron JC, PattiME, Klein SL,Weinstein RS&Scherer PE, 2003 Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin. Diabetes 52 268-276. (doi:10.2337/ diabetes.52.2.268)
15. Coschigano KT, Clemmons D, Bellush LL & Kopchick JJ, 2000 Assessment of growth parameters and life span of GHR/BP gene-disrupted mice. Endocrinology 141 2608-2613. (doi:10.1210/en.141.7.2608)
16. Coschigano KT, Holland AN, Riders ME, List EO, Flyvbjerg A & Kopchick JJ, 2003 Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span. Endocrinology 144 3799-3810. (doi:10.1210/en.2003-0374)
17. Ding J, List EO, Bower BD & Kopchick JJ, 2011 Differential effects of growth hormone versus insulin-like growth factor-I on the mouse plasma proteome. Endocrinology 152 3791-3802. (doi:10.1210/en.2011-1217)
18. Ebinuma H & Matsuo M, 2009 Protease-based ELISA for selective quantification of mouse high-molecular-weight adiponectin. Clinica Chimica Acta 401 181-183. (doi:10.1016/j.cca.2008.11.013)
19. von Eynatten M, Humpert PM, BluemmA, Lepper PM, Hamann A, Allolio B, Nawroth PP, Bierhaus A & Dugi KA, 2008 High-molecular weight adiponectin is independently associated with the extent of coronary artery disease in men. Atherosclerosis 199 123-128. (doi:10.1016/j. atherosclerosis.2007.10.002)
20. Fisher FM, Trujillo ME, Hanif W, Barnett AH, McTernan PG, Scherer PE & Kumar S, 2005 Serum high molecular weight complex of adiponectin correlates better with glucose tolerance than total serum adiponectin in Indo-Asian males. Diabetologia 48 1084-1087. (doi:10.1007/s00125-005-1758-7)
21. Flurkey K, Papaconstantinou J, Miller RA & Harrison DE, 2001 Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production. PNAS 98 6736-6741. (doi:10.1073/pnas.111158898)
22. Gahete MD, Cordoba-Chacon J, Anadumaka CV, Lin Q, Bruning JC, Kahn CR, Luque RM & Kineman RD, 2011 Elevated GH/IGF-I due to somatotrope-specific loss of both IGF-I and insulin receptors, alters glucose homeostasis and insulin sensitivity in a diet-dependent manner. Endocrinology 152 4825-4837. (doi:10.1210/en.2011-1447)
23. Hara K, Horikoshi M, Yamauchi T, Yago H, Miyazaki O, Ebinuma H, Imai Y, Nagai R& Kadowaki T, 2006 Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care 29 1357-1362. (doi:10.2337/dc05-1801)
24. Hattori N, 2009 Expression, regulation and biological actions of growth hormone (GH) and ghrelin in the immune system. Growth Hormone & IGF Research 19 187-197. (doi:10.1016/j.ghir.2008.12.001)
25. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K & Tobe K, 2006 Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. Journal of Clinical Investigation 116 1784-1792. (doi:10.1172/JCI29126)
26. Kanety H, Hemi R, Ginsberg S, Pariente C, Yissachar E, Barhod E, Funahashi T & Laron Z, 2009 Total and high molecular weight adiponectin are elevated in patients with Laron syndrome despite marked obesity. European Journal of Endocrinology 161 837-844. (doi:10.1530/EJE-09-0419)
27. Kern PA, Di Gregorio GB, Lu T, Rassouli N & Ranganathan G, 2003 Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-a expression. Diabetes 52 1779-1785. (doi:10.2337/diabetes.52.7.1779)
28. Lam KS, Xu A, Tan KC, Wong LC, Tiu SC & Tam S, 2004 Serum adiponectin is reduced in acromegaly and normalized after correction of growth hormone excess. Journal of Clinical Endocrinology and Metabolism 89 5448-5453. (doi:10.1210/jc.2003-032023)
29. Lara-Castro C, Luo N, Wallace P, Klein RL & Garvey WT, 2006 Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes 55 249-259. (doi:10.2337/diabetes.55.01.06.db05-1105)
30. Laron Z & Kopchick JJ, 2011 Laron Syndrome - From Man to Mouse: Lessons From Clinical and Experimental Experience. Berlin, London: Springer. List EO 2010 Effects of GH and IGF-1 treatments on body composition, glucosemetabolism and hepatic gene expression in obese/diabetic mice with nonalcoholic fatty liver disease. Growth Hormone & IGF Research 20(Supplement 1) S74-S75. (doi:10.1016/S1096-6374(10)70195-7)
31. List EO, Palmer AJ, Berryman DE, Bower B, Kelder B & Kopchick JJ, 2009 Growth hormone improves body composition, fasting blood glucose, glucose tolerance and liver triacylglycerol in a mouse model of dietinduced obesity and type 2 diabetes. Diabetologia 52 1647-1655. (doi:10.1007/s00125-009-1402-z)
32. List EO, Sackmann-Sala L, Berryman DE, Funk K, Kelder B, Gosney ES, Okada S, Ding J, Cruz-Topete D & Kopchick JJ, 2011 Endocrine parameters and phenotypes of the growth hormone receptor gene disrupted (GHRK/K) mouse. Endocrine Reviews 32 356-386. (doi:10.1210/er.2010-0009)
33. Liu JL, Coschigano KT, Robertson K, Lipsett M, Guo Y, Kopchick JJ, Kumar U & Liu YL, 2004 Disruption of growth hormone receptor gene causes diminished pancreatic islet size and increased insulin sensitivity in mice. American Journal of Physiology. Endocrinology and Metabolism 287 E405-E413. (doi:10.1152/ajpendo.00423.2003)
34. Louer CR, Furman BD, Huebner JL, Kraus VB, Olson SA & Guilak F 2012 Diet-induced obesity significantly increases the severity of posttraumatic arthritis in mice. Arthritis and Rheumatism 64 3220-3230. (doi:10.1002/art.34533)
35. Luque RM, Lin Q, Cordoba-Chacon J, Subbaiah PV, Buch T, Waisman A, Vankelecom H & Kineman RD, 2011 Metabolic impact of adult-onset, isolated, growth hormone deficiency (AOiGHD) due to destruction of pituitary somatotropes. PLoS ONE 6 e15767. (doi:10.1371/journal. pone.0015767).
36. Maeda K, Okubo K, Shimomura I, Funahashi T & Matsuzawa Y, 1996 cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochemical and Biophysical Research Communications 221 286-289. (doi:10.1006/bbrc. 1996.0587)
37. Magon V, 2009 Body composition and adipokine levels in growth hormone antagonist mice. In Health and Human Services, p 173. Athens: Ohio University. Dissertation for Master of Science submitted to Ohio University, Athens, OH, USA.
38. Masternak MM, Panici JA, Wang F, Wang Z & Spong A, 2010 The effects of growth hormone (GH) treatment on GH and insulin/IGF-1 signaling in long-lived Ames dwarf mice. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 65 24-30. (doi:10.1093/gerona/glp172)
39. Masternak MM, Bartke A, Wang F, Spong A, Gesing A, Fang Y, Salmon AB, Hughes LF, Liberati T, Boparai R et al. 2012 Metabolic effects of intraabdominal fat in GHRKO mice. Aging Cell 11 73-81. (doi:10.1111/j. 1474-9726.2011.00763.x)
40. McKee Alderman J, DePetrillo MA, Gluesenkamp AM, Hartley AC, Verhoff SV, Zavodni KL & Combs TP, 2010 Calorie restriction and dwarf mice in gerontological research. Gerontology 56 404-409. (doi:10.1159/000235720)
41. Nilsson L, Binart N, Bohlooly YM, Bramnert M, Egecioglu E, Kindblom J, Kelly PA, Kopchick JJ, Ormandy CJ, Ling C et al. 2005 Prolactin and growth hormone regulate adiponectin secretion and receptor expression in adipose tissue. Biochemical and Biophysical Research Communications 331 1120-1126.(doi:10.1016/j.bbrc.2005.04.026)
42. O'Leary VB, Jorett AE, Marchetti CM, Gonzalez F, Phillips SA, Ciaraldi TP & Kirwan JP, 2007 Enhanced adiponectin multimer ratio and skeletal muscle adiponectin receptor expression following exercise training and diet in older insulin-resistant adults. American Journal of Physiology. Endocrinology and Metabolism 293 E421-E427. (doi:10.1152/ajpendo. 00123.2007)
43. Olsson B, Bohlooly YM, Fitzgerald SM, Frick F, Ljungberg A, Ahren B, Tornell J, Bergstrom G & Oscarsson J, 2005 Bovine growth hormone transgenic mice are resistant to diet-induced obesity but develop hyperphagia, dyslipidemia, and diabetes on a high-fat diet. Endocrinology 146 920-930. (doi:10.1210/en.2004-1232)
44. Otabe S, Yuan X, Fukutani T, Wada N, Hashinaga T, Nakayama H, Hirota N, Kojima M & Yamada K, 2007 Overexpression of human adiponectin in transgenic mice results in suppression of fat accumulation and prevention of premature death by high-calorie diet. American Journal of Physiology. Endocrinology and Metabolism 293 E210-E218. (doi:10.1152/ ajpendo.00645.2006)
45. Pajvani UB, Hawkins M, Combs TP, Rajala MW, Doebber T, Berger JP, Wagner JA, Wu M, Knopps A, Xiang AH et al. 2004 Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. Journal of Biological Chemistry 279 12152-12162. (doi:10.1074/jbc. M311113200)
46. Palmer AJ, Chung MY, List EO, Walker J, Okada S, Kopchick JJ & Berryman DE, 2009 Age-related changes in body composition of bovine growth hormone transgenic mice. Endocrinology 150 1353-1360. (doi:10.1210/en.2008-1199)
47. Panici JA, Wang F, Bonkowski MS, Spong A, Bartke A, Pawlikowska L, Kwok PY & Masternak MM, 2009 Is altered expression of hepatic insulin-related genes in growth hormone receptor knockout mice due to GH resistance or a difference in biological life spans? Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 64 1126-1133. (doi:10.1093/gerona/glp111)
48. Qiao L, Lee B, Kinney B, Yoo HS & Shao J, 2011 Energy intake and adiponectin gene expression. American Journal of Physiology. Endocrinology and Metabolism 300 E809-E816. (doi:10.1152/ajpendo. 00004.2011)
49. del Rincon JP, Iida K, Gaylinn BD, McCurdy CE, Leitner JW, Barbour LA, Kopchick JJ, Friedman JE, Draznin B & Thorner MO, 2007 Growth hormone regulation of p85α expression and phosphoinositide 3-kinase activity in adipose tissue: mechanism for growth hormone-mediated insulin resistance. Diabetes 56 1638-1646. (doi:10.2337/db06-0299) S
50. ackmann-Sala L, Berryman DE, Lubbers ER, Vesel CB, Troike KM, List EO, Munn RD, Ikeno Y & Kopchick JJ, 2012a Decreased insulin sensitivity and increased oxidative damage in wasting adipose tissue depots of wild-type mice. Age 34 1225-1237. (doi:10.1007/s11357-011-9304-7)
51. Sackmann-Sala L, Berryman DE, Munn RD, Lubbers ER & Kopchick JJ, 2012b Heterogeneity among white adipose tissue depots in male C57BL/6J mice. Obesity 20 101-111. (doi:10.1038/oby.2011.235)
52. Schautz B, Later W, Heller M, Peters A, Muller MJ & Bosy-Westphal A, 2012 Impact of age on leptin and adiponectin independent of adiposity. British Journal of Nutrition 108 363-370. (doi:10.1017/ S0007114511005605)
53. StantonMC, Chen SC, Jackson JV, Rojas-Triana A, Kinsley D, Cui L, Fine JS, Greenfeder S, Bober LA & Jenh CH, 2011 Inflammatory signals shift from adipose to liver during high fat feeding and influence the development of steatohepatitis in mice. Journal of Inflammation 8 8. (doi:10.1186/1476-9255-8-8)
54. Trujillo ME & Scherer PE, 2006 Adipose tissue-derived factors: impact on health and disease. Endocrine Reviews 27 762-778. (doi:10.1210/ er.2006-0033)
55. Waki H, Yamauchi T, Kamon J, Ito Y, Uchida S, Kita S, Hara K, Hada Y, Vasseur F, Froguel P et al. 2003 Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. Journal of Biological Chemistry 278 40352-40363. (doi:10.1074/jbc.M300365200)
56. Wang, X, 2012 Verifying the Deletion of Growth Hormone Receptor Using a Quantitative Polymerase Chain Reaction at the mRNA Level in Tissue-Specific GHR-/- Mice Dissertation for Master of Science submitted to Academic department, School of Applied Health Sciences and Wellness, College of Health Sciences and Professions, Ohio University, Athens, OH, USA
57. Wang Z, Al-Regaiey KA, Masternak MM & Bartke A, 2006 Adipocytokines and lipid levels in Ames dwarf and calorie-restricted mice. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 61 323-331. (doi:10.1093/gerona/61.4.323)
58. Wang Z, Masternak MM, Al-Regaiey KA & Bartke A, 2007 Adipocytokines and the regulation of lipid metabolism in growth hormone transgenic and calorie-restricted mice. Endocrinology 148 2845-2853. (doi:10.1210/en.2006-1313)
59. Wang Y, Lam KS, Yau MH & Xu A, 2008 Post-translational modifications of adiponectin: mechanisms and functional implications. Biochemical Journal 409 623-633. (doi:10.1042/BJ20071492)
60. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N et al. 2001 The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nature Medicine 7 941-946. (doi:10.1038/ 90984)
61. Zhou Y, Xu BC, Maheshwari HG, He L, Reed M, Lozykowski M, Okada S, Cataldo L, Coschigamo K, Wagner TE et al. 1997 A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). PNAS 94 13215-13220. (doi:10.1073/pnas.94.24.13215)